It’s not easy to organize a marathon. You need to get permits to use the roads, you need to plot out a course, you need to find vendors and sponsors and volunteers and safety professionals and, above all, runners.
As shitty as it sounds, the bombing at the Boston marathon helped bring attention to road races. People want to run to show their solidarity. This is all over the Western world, mind you – not just in the US. That’s why my partner and I got the idea to put on this race in Belfast. He’s from there, I love the city, and hell, what better a location to conduct a marathon than a place with the word “fast” in its name? The marketing writes itself.
The Belfast city council approved the marathon pretty quickly. It didn’t conflict with any other road event and Belfast was doing some citywide “healthy living” campaign, so another road race only helped draw attention to it. Continue reading “Runners, part 1”
GeneMedica General Memo Rakesh Chandrasekhar March 16, 2015
The cursory observations from Kyle Arrington’s field reports and preliminary data suggest we might be on the right track. I had the bulk of the samples collected by the expedition sent for sequencing and analysis. AppDyn is waiting for our results before they can proceed with their own work with their amplifiers and transceivers, but the merger is slowing everything down on their end.
The portion of samples that were sent directly to the test labs are showing promise. The fail points of MR1 through MR331 aren’t an issue with MR332. Transmissibility among mammals via spore burst and secondary pathways is still lower than our target, however.
GeneMedica General Memo Rakesh Chandrasekhar March 17, 2015
I talked Rakesh Patel from AppDyn into loaning us one of their new transceivers. It’ll be set up by tomorrow, which is perfect because the sequencing and analysis on MR332 will be available tomorrow morning.
The overnight guys in Lab 4 had a small breakthrough when it was discovered that MR332 had had a 100% transmission rate when applied to flies. Tissue degradation is still the main concern, however, as it decreases the secondary transmission radius. Fly mortality was 96% within the first hour and 100% by the third.
GeneMedica General Memo Rakesh Chandrasekhar March 20, 2015
Our researchers have been unable to successfully bind MR332 zygospores to AppDyn’s most recent respirocyte iteration. AppDyn is unwilling to provide us with its full design specifications, claiming they will only be made available once the GeneMedica/AppDyn merger is complete.
This is a major setback, as the bulk of our models were built on the assumption of a successful zygospore/respirocyte synthesis. That said, the respirocytes are still sensitive to on/off broadcasts made by the AppDyn transceiver I secured from Rakesh Patel.
Mice exposed to the pure respirocytes were able to exert themselves approximately 4000% above baseline. Structural damage of legs and feet was within expected levels. This percentage will need to increase exponentially to meet the modelled goal.
GeneMedica General Memo Rakesh Chandrasekhar March 23, 2015
There have been suggestions that the failure of zygospore and respirocyte synthesis can be mitigated by our hemoengineering technologies. While I understand the thought process behind the suggestion, I’m uncertain about its overall feasibility. It would require significant, stealthy acquisitions of hospitals, blood banks, and other medical facilities using capital beyond what GeneMedica has available. I’ll suggest looking into this again after the merger, but considering the cost and the enormous risk involved, I’m not increasing our hemoengineering budget. We will continue working on the synthesis.
GeneMedica General Memo Rakesh Chandrasekhar March 24, 2015
AppDyn sent us their preliminary results on our model-based zygospore/respirocyte synthesis and the model’s receptivity to early PHz transceiver signal models. As predicted, the respirocytes embedded within spores will take complex commands while inside a host. This would be a big relief to me if we weren’t just talking about models that still aren’t reflecting reality.
CONFIDENTIAL – GeneMedica Emergency Memo CONFIDENTIAL – 11A access only CONFIDENTIAL – Rakesh Chandrasekhar CONFIDENTIAL – March 25, 2015
Dr. Erin McConnell: deceased Dr. Arthur Crane: deceased Dr. Abasi Ndoga: deceased Dr. Li Chen: deceased Dr. Annette Chang: alive
I’ve ordered the immediate shutdown of Lab 4 located in sub-basement 3, and the interview and indefinite quarantine of the survivor.
DVR footage shows Dr. Li Chen surreptitiously emptying a vial of zygospores onto the floor of the sample lab. The sample lab does not require a cleansuit for entry. Drs. McConnell, Crane, Ndoga, and Chen began showing symptoms within minutes. Dr. Crane was able to sound the alarm and initiate a lockdown before being overcome.
Dr. Chang returned from the restroom immediately following the lockdown and was able to view the zygospore effects upon Drs. McConnell, Crane, Ndoga, and Chen from the lab window. DVR footage showed the zygospore effects on the doctors were in line with the field observations of Kyle Arrington, albeit far faster due to the artificially-concentrated zygospores used for testing purposes.
A note was found in Dr. Chen’s locker which read, “We will be the first ones to travel.”
I’ve ordered sub-basement 3 to be incinerated following the collection of samples from the flesh of the deceased. Labs 1 – 3 and 5 – 28 will be unaffected and researchers will be kept unaware of the event.
This setback is not expected to affect the GeneMedica/AppDyn merger, although the loss of zygospore samples as well as four doctors will hinder the progress toward zygospore/respirocyte synthesis. AppDyn is being notified of the incident.